Objectives: To assess the performance of T2Candida for the diagnosis of invasive candidiasis (IC) against gold standards of candidaemia or consensus IC definitions, and to evaluate the impact of T2Candida on antifungal drug prescribing.
Methods: A retrospective review was undertaken of all T2Candida (T2MR technology, T2 Biosystems) performed from October 2020 to February 2022. T2Candida performance was evaluated against confirmed candidaemia or against proven/probable IC within 48 hours of T2Candida, and its impact on antifungal drug prescriptions.
Results: T2Candida was performed in 61 patients, with 6 (9.8%) positive results. Diagnostic performance of T2Candida against candidaemia had a specificity of 85.7% and negative predictive value (NPV) of 96.8%. When comparing T2Candida results with consensus definitions of IC, the specificity and NPV of T2Candida was respectively 90% (54/60) and 98.2% (54/55) for proven IC, and 91.4% (53/58) and 96.4% (53/55) for proven/probable IC. Antifungals were initiated in three of six patients (50%) with a positive T2Candida result. Thirty-three patients were receiving empirical antifungals at the time of T2Candida testing, and a negative result prompted cessation of antifungals in 11 (33%) patients, compared with 6 (25%) antifungal prescriptions stopped following negative beta-d-glucan (BDG) testing in a control population ( = 24).
Conclusions: T2Candida shows high specificity and NPV compared with evidence of bloodstream infection or consensus definitions for invasive infection, and may play an adjunctive role as a stewardship tool to limit unnecessary antifungal prescriptions.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076932 | PMC |
| http://dx.doi.org/10.1093/jacamr/dlad035 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A case of Ustilago spp. infection identified by whole genome sequencing in a pediatric patient undergoing open-chest extracorporeal membrane oxygenation.
Int J Infect Dis
November 2024
Microbiology and Diagnostic Immunology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Article Synopsis
- A 3-year-old male on ECMO for respiratory failure developed a fungal infection from a rare pathogen that couldn't be identified by standard testing methods.
- Despite a negative T2Candida panel, blood cultures became positive after 4 days, and traditional identification methods failed, leading to whole genome sequencing (WGS) for precise identification.
- WGS revealed the fungus belonged to the Ustilago genus, and thanks to timely treatment adjustments, the infection was successfully eradicated, highlighting the significance of advanced molecular techniques in diagnosing rare infections.
Optimizing treatment outcomes in acute-on-chronic liver failure: The role of T2candida panel in detecting invasive candidiasis.
Am J Med Sci
November 2024
University of Alabama at Birmingham, Birmingham, AL, USA.
Introduction: Acute-on-Chronic Liver Failure(ACLF) is a syndrome characterized by organ dysfunction and high mortality in cirrhotic patients. ACLF has multiple triggers but those precipitated by fungal infection have higher mortality. Early detection and treatment of candidemia have shown mortality benefits in ACLF.
View Article and Find Full Text PDFClinical evaluation of the T2Candida assay for the rapid diagnosis of candidemia.
Diagn Microbiol Infect Dis
September 2024
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
We evaluated the clinical performance of the T2Candida assay. The overall agreement of the T2Candida assay results with the blood culture results was 95.3 % (121/127).
View Article and Find Full Text PDFIs the T2MR Candida Panel a suitable alternative to the SeptiFast for the rapid diagnosis of candidemia in routine clinical practice?
Clin Microbiol Infect
June 2024
Division of Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. Electronic address:
Objectives: The diagnosis of invasive Candida infection remains challenging because of tests with slow turnaround times or mediocre performance. T2magnetic resonance imaging is a new diagnostic tool. We investigated the diagnostic accuracy of the T2Candida panel (T2) in comparison with blood culture (BC) and the SeptiFast (SF) for the detection of five different Candida species among high-risk intensive care unit patients with suspected candidemia.
View Article and Find Full Text PDFUtility of incorporation of beta-D-glucan and T2Candida testing for diagnosis and treatment of candidemia.
Diagn Microbiol Infect Dis
February 2024
Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA; Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA.
The additive role of non-culture-based methods for the diagnosis of candidemia remains unknown. We evaluated 2 clinical practices followed in our hospitals for the diagnosis of candidemia, namely practice#1 including a combination of blood cultures and T2Candida, and practice#2 that also included Beta-D-glucan (BDG). Three out of 96 patients testing positive with practice#1 received a complete antifungal course.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!